Navigation Links
Genetic Reporter Systems

Genetic reporter systems have developed into an essential tool for examining regulatory promoter and enhancer sequences as well as transcription factors. In most cases, the element under investigation (promoter, enhancer) is cloned together with the reporter gene in an expression vector, which is subsequently used to transfect cells. Quantification of the reporter indirectly provides information on the transcription activity of the element under investigation. Quantification can take place by detecting the corresponding RNA, the reporter protein, or by measuring the enzyme activity of the reporter protein. When the reporter system is selected, care must be taken to ensure that the reporter gene does not influence the physiology of the transfected cells and that the gene is not already endogenously expressed in the examined cells.

Reporter systems are also often used as a standard to compare the transfection efficiency of different transfection experiments. In this case, the control reporter system usually contains a constitutive promoter and a reporter gene, which is different to the reporter gene used by the element under examination. Such a reporter system can also be used to optimize electroporation parameters.

Chloramphenicol Acetyltransferase (CAT)

Chloramphenicol Acetyltransferase (CAT) This enzyme comes from microorganisms and catalyzes the transfer of acetyl groups from acetyl coenzyme A to chloramphenicol. With the CAT assay, the CAT-containing lysates of transfected cells are incubated with 14C-chloramphenicol, which is then acetylated. Acetylated and non-acetylated 14C-chloramphenicol is then separate d using thin-layer chromatography and visualized by autoradiography. If necessary, the distribution of radioactivity can be quantified by a scanning system.

As an increasingly common, non-radioactive alternative, CAT expression is quantified by an ELISA via immunological detection of the CAT enzyme which has been expressed.


The prokaryotic -galactosidase naturally catalyzes the hydrolysis of -galactosides (e.g. lactose). However, the use of non-physiological substrates also enables the quantification of -galactosidase activity in lysates of transfected cells via spectrophotometry (e.g. with 0-nitrophenyl--D-galactoside = ONPG), fluorometry (e.g. with a 4-methyl-umbelliferyl--galactopyranoside compound = MUG) or via chemiluminescence. Detection by chemiluminescence (e.g. with 1.2 dioxetan-galactopyranoside derivatives) is 1001,000 times more sensitive than the other two detection methods, and thus even more sensitive than the luciferase assay (see below). A major advantage of this system is the fact that -galactosidase activity can also be measured in situ.

The -galactosidase reporter gene is often co-transfected together with other reporter systems as an internal control. The -galactosidase activities can be used to compare and standardize different transfection experiments (e.g. luciferase assays).

Human Growth Hormone (hGH)

With the human Growth Hormone (hGH) reporter system in contrast to most other systems the reporter protein is secreted into the culture medium by the transfected cells. This means that cell lysis is not necessary for quantifying the reporter protein. Detection of the secreted hGH is usu ally carried out using 125I-labeled antibodies against the growth hormone. Several manufacturers supply a non-radioactive alternative in the form of ELISA kits, with anti-hGH antibodies bound to the surface of a microtiter plate. First, the hGH from the supernatant of the culture medium binds to the antibody on the plate. Subsequently, the bound hGH is detected in two steps via a digoxigenin- coupled anti-hGH antibody and a peroxidase-coupled anti-digoxigenin antibody. Bound peroxidase is quantified by incubation with a substrate.

Another secreted reporter protein is the SEAP (secreted alkaline phosphatase). This protein is quantified directly by measuring the enzyme activity in the supernatant of the culture medium. Fluorescence and chemiluminescence assays are available for this purpose.

Firefly Luciferase

The enzyme from the North American firefly (Photinus pyralis) catalyzes a bioluminescence reaction. In the luciferase assay, the lysates of transfected cells are incubated with luciferin, molecular oxygen, ATP and Mg2+. In the following reaction, the luciferase catalyzes the oxidation of luciferin in oxyluciferin and CO2. In this reaction, light with a wavelength of 562 nm is emitted, which then fades rapidly. The light emitted can be measured in a luminometer or in a liquid-scintillation counter. Light emission is proportional to the amount of luciferase in the lysate, thus enabling the indirect quantification of the transfection rate of the reporter gene. The sensitivity of the luciferase assay is further increased by adding co-enzyme A to the reaction preparation, rendering it 1020 times more sensitive than the CAT assay.

In a fur ther development of the luciferase assay, cells are co-transfected with a control plasmid of a different luciferase from renilla (Renilla reniformis). The activities of firefly and renilla luciferase can be measured separately in one sample. The activity of the renilla luciferase can therefore be used as an internal control for comparing different transfection experiments. Both luciferases are also used in co-transfection experiments for the parallel examination of two cis elements.

Green Fluorescent Protein (GFP)

Unlike other bioluminescent reporters, the green fluorescent protein from the Aequorea victoria jellyfish requires no additional proteins, substrates or co-factors to emit light. When irradiated with UV light or blue light, it emits green light, which enables the examination of gene expression and protein localization in situ and in vivo. In addition, the gene expression can be observed in real time. However, the system is less suitable for quantifying the gene expression.

Variations of GFP with different absorption and emission maxima also enable double-labeling experiments, such as the simultaneous examination of gene expression of two promoters in one cell, or the location of two different fusion proteins in one cell. Other variations of GFP are particularly designed for expression in mammalian cells or have up to a 35-fold higher fluorescence. With the aid of a GFP system with a drastically reduced half-life, dynamic processes can also be examined in vivo in the cell.



Page: All 1 2 3 4

Related biology technology :

1. Map and Link Human Genetic Disorders with SSLP Analysis
2. Genetic Reporter Systems
3. Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing
4. Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System
5. The iCycler iQ and Amplifluor Detection Systems for Analysis of Genetically Modified Organisms in Foodstuffs, Rev A
6. Analysis of Bacterial Assemblage Genetic Diversity in Environmental Samples Using the DCode System
7. Monitoring Bacterial Genetic Diversity in a Freshwater Lake Using TTGE and DNA Sequence Analysis
8. Rapid, High Throughput Mutation Discovery Using Fluorescent SSCP on the ABI PRISM 3100 and 3100Avant Genetic Analyzers
9. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
10. Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion Transactivators
11. Versatile Reporter Vectors for Monitoring Viral Transduction
Post Your Comments:

(Date:10/12/2015)... ... 12, 2015 , ... Spirax Sarco, the leader in products and services for ... compact clean steam generator . This unit is a skid mounted system that ... and EN285 standards. The CMS-C 600 generator can produce up to a maximum ...
(Date:10/12/2015)... -- cell surface marker detection market is ... a new report by Grand View Research, Inc. This growth ... oncology diseases and other cell-associated disorders. --> cell ... 6.49 billion by 2022, according to a new report by ... attributed to rise in incidence of oncology diseases and other ...
(Date:10/12/2015)... CAESAREA, Israel , October 12, 2015 ... of the Dario™ Diabetes Management Solution, today announced its ... a patient case study at MobiHealth,s 5th EAI ... Focused on, "Transforming healthcare through innovations in mobile and ... London, England from October 14 - ...
(Date:10/12/2015)... ... 12, 2015 , ... NeuMedics Inc., is a specialty biopharmaceutical company focused on ... and chronically be administered as an eye drop, announced today it has been selected ... and taking place October 25th to October 28th at The Cleveland Clinic, Cleveland, Ohio. ...
Breaking Biology Technology:
(Date:9/29/2015)... 2015  iDAvatars is excited to be named one of ... market. The official announcement was recently made at an invite-only ... San Francisco , where iDAvatars presented a ... Watson. "It is both an honor and a ... bring to market the cognitive power of IBM Watson in ...
(Date:9/28/2015)... SAN JOSE, Calif. , Sept. 28, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that Lenovo ... area touch fingerprint sensor, FS4202, for its latest smartphone, ... enables secure, password-free access to unlock the device and ... consumers. The feature-rich Natural ID FS4202 ...
(Date:9/10/2015)... Sept. 10, 2015 Report Details ... Reveals Selling Opportunities and Revenue Prospects to Help ... of biologics, especially new drug classes? Get the ... ahead with exclusive market data and industry knowledge, ... developments, results, opportunities and sales predictions. Visiongain,s ...
Breaking Biology News(10 mins):